Tuesday, July 26, 2016 4:43 AM
|
CCSVI in Multiple Sclerosis
Venous stenting is improving cerebral blood flow, less intracranial pressure and symptom relief for Ehler Danlos patients--ongoing studies are being done at University of Virginia. Over 50 patients treated--no placebo controlled trials, no pharma influence, no outrage from neurologists, no claims of PLACEBO! with symptom reduction. Some patients have been followed for 10 years, and are doing well. Where's the FDA saying no? Where's the outrage? Where are the negative studies published in neurology journals claiming patient delusion? Interesting, eh? Joan Since we first published an article about the use of venous stents to treat pseudotumor cerebri last year, the story has been widely shared on social media. The interest is especially high among one group in particular: patients diagnosed with Ehlers-Danlos syndrome (EDS), an inherited connective ti...
|